Trillet-Lenoir V - Search Results

1

Assessment of Patient Reported Outcomes (PROs) in Outpatients Taking Oral Anticancer Drugs Included in the Real-Life Oncoral Program.

Collomb B, Dubromel A, Caffin AG, Herledan C, Larbre V, Baudouin A, Cerutti A, Couturier L, Maire M, Karlin L, Maucort-Boulch D, Huot L, Dalle S, Bachy E, Ghesquieres H, Salles G, Couraud S, You B, Freyer G, Trillet-Lenoir V, Ranchon F, Rioufol C. Collomb B, et al. Among authors: trillet lenoir v. Cancers (Basel). 2022 Jan 28;14(3):660. doi: 10.3390/cancers14030660. Cancers (Basel). 2022. PMID: 35158928 Free PMC article.

2

[Adjuvant treatment of colonic cancers].

Freyer G, Descos L, Trillet-Lenoir V, Chang DH, Gérard JP. Freyer G, et al. Presse Med. 1996 Sep 21;25(27):1241-6. Presse Med. 1996. PMID: 8949736 Review. French.

3

Pharmacokinetic studies in cancer chemotherapy: usefulness in clinical practice.

Freyer G, Ligneau B, Tranchand B, Ardiet C, Serre-Debeauvais F, Trillet-Lenoir V. Freyer G, et al. Cancer Treat Rev. 1997 May;23(3):153-69. doi: 10.1016/s0305-7372(97)90036-0. Cancer Treat Rev. 1997. PMID: 9251720 Review. No abstract available.

4

[Advantage of using tumor markers in colorectal and breast cancers. Guidelines of the American Society of Clinical Oncology (ASCO)].

Trillet-Lenoir V, Freyer G. Trillet-Lenoir V, et al. Bull Cancer. 1997 Jul;84(7):767-8. Bull Cancer. 1997. PMID: 9339206 French. No abstract available.

5

Colony-stimulating factors in the prevention of solid tumors induced by chemotherapy in patients with febrile neutropenia.

Freyer G, Ligneau B, Trillet-Lenoir V. Freyer G, et al. Int J Antimicrob Agents. 1998 Apr;10(1):3-9. doi: 10.1016/s0924-8579(98)00016-8. Int J Antimicrob Agents. 1998. PMID: 9624538 Review.

6

[Management of nonresectable non-small cell lung cancer. Recommendations of the American Society of Clinical Oncology (ASCO)].

Bompas E, Freyer G, Trillet-Lenoir V. Bompas E, et al. Bull Cancer. 1998 Feb;85(2):125-7. Bull Cancer. 1998. PMID: 9752328 Free article. French. No abstract available.

7

Endometrial mesodermal mixed tumor occurring after tamoxifen treatment: report on a new case and review of the literature.

Dumortier J, Freyer G, Sasco AJ, Frappart L, Zénone T, Romestaing P, Trillet-Lenoir V. Dumortier J, et al. Ann Oncol. 2000 Mar;11(3):355-8. doi: 10.1023/a:1008338231169. Ann Oncol. 2000. PMID: 10811505 Free article. Review.

8

[Granulosa cell tumour: review of the literature].

Bompas E, Freyer G, Vitrey D, Trillet-Lenoir V. Bompas E, et al. Bull Cancer. 2000 Oct;87(10):709-14. Bull Cancer. 2000. PMID: 11084534 Free article. Review. French.

9

Palliative hormone therapy, low-dose chemotherapy, and bisphosphonate in breast cancer patients with bone marrow involvement and pancytopenia: report of a pilot experience.

Freyer G, Ligneau B, Trillet-Lenoir V V. Freyer G, et al. Eur J Intern Med. 2000 Dec 20;11(6):329-333. doi: 10.1016/s0953-6205(00)00121-7. Eur J Intern Med. 2000. PMID: 11113657

10

Addition of oxaliplatin to continuous fluorouracil, l-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 phase I trial.

Freyer G, Bossard N, Romestaing P, Mornex F, Chapet O, Trillet-Lenoir V, Gérard JP. Freyer G, et al. J Clin Oncol. 2001 May 1;19(9):2433-8. doi: 10.1200/JCO.2001.19.9.2433. J Clin Oncol. 2001. PMID: 11331322

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters